Organ Preservation Solutions Market worth 456.06 Million USD by 2025

Definition: Solutions used to store organs and minimize tissue damage, particularly while awaiting implantation.

February 2019 | Material and Chemicals

S.A.L.F. offers a range of solutions for organ preservation (also hypothermic) used to spray isolated organs immediately before or immediately after being removed from the donor and for organ preservation before implantation.

Organ Preservation Solutions Market By Solution siRNA Transplant Solutions, Lifor, Viaspan, HypoThermosol, Human Biosystems HBS Solution, Custodiol HTK Histidine-Tryptophan-Ketoglutarate Solution, RENOGRA, PERFADEX and Other Solutions and Preservation Technique Static Cold Storage SCS , Hypothermic Perfusion Preservation HPP and Other Preservation Techniques - Global Industry Analysis And Forecast To 2025 

Industry Outlook

Organ Preservation is a field that is supply line for organ transplantation. Organs like pancreas, kidney & liver are preserved successfully currently, by flushing with the Organ Preservation Solution and storing them at temperature between 0-5 degrees C hypothermia. Some Organ Preservation Solutions have the property of preventing the organ from swelling during cold storage due to use of cell impermeant agents like hydroxyethyl starch, raffinose, lactobionic, etc. Moreover, the solutions also contain adenosine & glutathione, which are responsible for stimulating recovery of normal metabolism by increasing capacity of organs related to antioxidant or else stimulating high energy phosphate generation adenosine after regulating the flow of blood. Organs like pancreas, kidney & liver are well preserved as compared to lungs & heart which need more research to develop solution to preserve them that well. Some factors for the growing use of Organ Preservation Solutions are; increasing number of partnerships developing between medical institutes & research organizations, rising advancement in the healthcare sector, etc. Therefore, the Organ Preservation Solutions Market is anticipated to expand and has tremendous scope during the forecast period. The global Organ Preservation Solutions Market anticipated flourishing in the future by growing at a significantly higher CAGR. 

Market Segmentation 

The global Organ Preservation Solutions Market is based on segment, by Solution the market is segmented into siRNA Transplant Solutions, Lifor, Viaspan, HypoThermosol, Human BioSystems HBS Solution, Custodiol HTK Histidine-Tryptophan-Ketoglutarate Solution, RENOGRA, PERFADEX and Other Solutions, and by Preservation Technique the market is segmented into Static Cold Storage SCS , Hypothermic Perfusion Preservation HPP and Other Preservation Techniques.

 

Table of Commonly Used Preservative Solutions

Component

Euro-Collins

UW

HTK

Celsior

Sodium (mmol/L)

00

00

00

00

Potassium (mmol/L)

00

00

00

00

Magnesium( mmol/L)

00

00

00

00

Calcium (mmol/L)

00

00

00

00

Sulfate (mmol/L)

00

00

00

00

Lactobionate (mmol/L)

00

00

00

00

Phosphate (mmol/L)

00

00

00

00

Raffinose (mmol/L)

00

00

00

00

Adenosine (mmol/L)

00

00

00

00

Glutathione (mmol/L)

00

00

00

00

Allopurinol (mmol/L)

00

00

00

00

Ketoglutarate/Glutamic Acid (mmol/L)

00

00

00

00

Histidine (mmol/L)

00

00

00

00

Starch (gm/L)

00

00

00

00

Mannitol (mmol/L)

00

00

00

00

Glucose (mmol/L)

00

00

00

00

Tryptophan (mmol/L)

00

00

00

00

Osmolarity (mOsm/L)

00

00

00

00

 

Organ Preservation Solutions Market, By Solution

siRNA Transplant Solutions
Lifor
Viaspan
HypoThermosol
Human BioSystems HBS Solution
Custodiol HTK Histidine-Tryptophan-Ketoglutarate Solution
RENOGRA
PERFADEX
Other Solutions

Organ Preservation Solutions Market, By Preservation Technique

Static Cold Storage SCS 
Hypothermic Perfusion Preservation HPP 
Other Preservation Techniques

Regional Insights

On a global front, the Organ Preservation Solutions Market covers North America United States, Canada and Mexico , Europe Germany, UK, France, Russia, Italy, Rest of Europe , Asia-Pacific China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific , South America Brazil, Argentina, Columbia, Rest of South America and Middle East and Africa Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA. 

Get More Information about this Report @ https://www.planetmarketreports.com/reports/organ-preservation-solutions-market-3340

Organ Preservation Solutions Market, By Region

North America

U.S. 
Canada 
Mexico 

Europe

Germany 
UK 
France 
Russia 
Italy 
Rest of Europe 

Asia-Pacific

China 
Japan 
South Korea 
India 
Southeast Asia 
Rest of Asia-Pacific 

South America

Brazil 
Argentina 
Columbia 
Rest of South America 

Middle East and Africa

Saudi Arabia 
UAE 
Egypt 
Nigeria 
South Africa 
Rest of MEA 

Competitive Analysis

The leading players in the market are21st Century Medicine, Dr. Franz Köhler Chemie GmbH, CryoLife Inc., Teva Pharmaceutical Industries Ltd., BioLife Solutions Inc., Claris Lifesciences Limited, BioTime Inc., Lifeline Scientific, ToleroTech Inc., Bristol-Myers Squibb and XVIVO Perfusion AB. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.

21st Century Medicine
Dr. Franz Köhler Chemie GmbH 
CryoLife Inc. 
Teva Pharmaceutical Industries Ltd. 
BioLife Solutions Inc. 
Claris Lifesciences Limited 
BioTime Inc. 
Lifeline Scientific 
ToleroTech Inc. 
Bristol-Myers Squibb 
XVIVO Perfusion AB

Some of the key questions answered by the report are: 

What was the market size in 2014 and forecast from 2015 to 2025?
What will be the industry market growth from 2015 to 2025?
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
What are the major segments leading the market growth and why?
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?